Document is current
Any future updates will be listed below
-
Authors
Cosentino, Katia https://orcid.org/0000-0002-3796-3500
Verduijn, Joost
Galluzzi, Lorenzo https://orcid.org/0000-0003-2257-8500
- License Information
-
More Information
Article History
First Online: 19 May 2025
Competing interests
: L.G. is/has been holding research contracts with Lytix Biopharma, Promontory and Onxeo, has received consulting or advisory honoraria from Boehringer Ingelheim, AstraZeneca, AbbVie, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Imvax, Sotio, Promontory, Noxopharm, EduCom, and the Luke Heller TECPR2 Foundation, and holds Promontory stock options. K.C. and J.V. have no conflicts of interest to declare.
